Company Introduction

PiVOT is a leading Contract Research Organization (CRO) in the Philippines. With over 100 years of aggregate employee experience in clinical research - from multinational companies like Pfizer, Novartis, Boehringer-Ingelheim, GlenEagles, PPD, and IQVIA (formerly Quintiles) - we obtained our license to operate from the Philippine Food and Drug Administration in 2018.
 
We are 100% owned by First Philippine Holdings Corp., a publicly-listed, Lopez-owned company, with assets of US$9B and attributable recurring net income of US$200M in power generation, real estate, construction, manufacturing, education, and healthcare.

Brief description of main products or services 

PiVOT provides a wide array of clinical trial services.
 
Our Clinical Trial Management team can handle drug and device trial management for Phase I to IV including Post Marketing Surveillance and Real World Evidence studies, from small-scale drugs, biologics, and devices to large, full-scale 5,000-patient vaccine trials. We are currently managing several COVID vaccine trials in the Philippines.
 
Our Clinical Trial Support Service covers such critical areas as:

• End-to-end 24/7 monitoring and aggregate regulatory reporting, for Pharmacovigilance
• Medical Writing, for protocols, publications, and grant applications
• Health Technology Assessment, for inclusions into the national formulary
• Support for local principal investigators conducting Investigator-Initiated Research
• Regulatory Affairs to keep you up to date with the latest local regulations